Heart Disease Clinical Trials in Houston

Showing 121-140 of 186 trials

Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease

NCT01587651

This is a Phase 4, multicenter, open-label (blinded Pharmacodynamic PD results), randomized, 3-arm, parallel-design study of subjects with stable Coronary Artery Disease CAD. This study will compare the PD effect of prasugrel 10 mg QD (once-daily) maintenance dose with ticagrelor 90 mg BID (twice daily) maintenance dose in subjects with stable CAD who have previously received ticagrelor loading does (LD) and maintenance dose (MD)..

Coronary Artery Disease

Daiichi Sankyo110 participantsStarted Mar 2012

Jacksonville, Florida, United States • Miami, Florida, United States • Port Orange, Florida, United States +10 more locations

COMPLETED< 1 mile

Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study

NCT00991120

The purpose of the Extension Phase of the COMPASS-HF study is to continue to observe the safety of the Chronicle® Implantable Hemodynamic Monitor (IHM) system and Chronicle ICD system and provide study doctors continued access to the heart pressure information recorded by the Chronicle devices which may be used to help manage heart failure. The Extension Phase of the COMPASS-HF study is limited to people who have already received the investigational system and are currently enrolled in a Chronicle IHM or ICD study.

Heart Failure

Medtronic Cardiac Rhythm and Heart Failure165 participantsStarted Oct 2009

Birmingham, Alabama, United States • Springfield, Illinois, United States • Fort Wayne, Indiana, United States +16 more locations

Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease

Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study

Heart Disease Trials in Other Cities

The IMPULSE Study: Pilot

Naltrexone/Bupropion Cardiovascular Outcomes Study

Effect of Pexelizumab on All-Cause Mortality and Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardio-Pulmonary Bypass

Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)

Randomized, Double-Blind, Placebo Controlled Study of the Short Term Clinical Effects of Tolvaptan in Patients Hospitalized for Worsening Heart Failure With Challenging Volume Management

Safety and Efficacy of Mipomersen (ISIS 301012) As Add-on Therapy in High Risk Hypercholesterolemic Patients

Study To Evaluate D-Ribose For The Treatment of Congestive Heart Failure

Ticagrelor vs. Prasugrel Effects on Infarct Size

Niacin Plus Statin to Prevent Vascular Events

ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab

An Assessment of the Glider Balloon in Complex Lesions

Echocardiography Guided Cardiac Resynchronization Therapy (EchoCRT)

Safety and Efficacy of Automatic Testing Feature in New ICDs and CRT-Ds

A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery

NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation

Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)

Heart Outcomes Prevention and Evaluation 4

Pharmacist-led Group Medical Visits to Help With Diabetes Management

Other Conditions in Houston